Diet

GLP-1 Medications and Exercise: What Official Guidance Says (and How to Approach It Safely)

Juline Garcia February 3, 2026

Important: This article is for general education only. It is not medical advice. GLP-1 medications are prescription drugs with real risks and real contraindications. And starting (or changing) an exercise routine can be risky for some people depending on health history. If you’re considering a GLP-1 medication, or you’re planning to increase physical activity, the safest move is to talk with a licensed clinician who can review your situation.

Also: beware of “viral stats” like “80% of people see huge improvements in 3 months.” Those numbers often float around without a real study behind them. When evidence is strong, it usually comes from FDA labeling (which summarizes clinical trials), major medical guidelines, or peer-reviewed research—not screenshots, influencer posts, or anonymous testimonials.

1) What counts as a “GLP-1” (and why exercise is part of the conversation)

GLP-1 (glucagon-like peptide-1) receptor agonists (and related drugs) are prescription medications used for certain metabolic conditions. Some are FDA-approved specifically for chronic weight management; others are approved for type 2 diabetes and may be used off-label for weight management under clinician supervision.

  • FDA-approved for chronic weight management (examples): Wegovy (semaglutide) and Zepbound (tirzepatide).
  • FDA-approved for type 2 diabetes (examples): Ozempic (semaglutide) and Mounjaro (tirzepatide).

Here’s the key detail people miss: the official FDA labeling for the weight-management versions doesn’t present these drugs as “medication only.” The indication is explicitly paired with lifestyle changes.

For diabetes indications, you’ll see similar “adjunct to diet and exercise” language in labeling for Ozempic and Mounjaro: Ozempic label (PDF), Mounjaro label (PDF).

Translation: “GLP-1 + activity” isn’t a social media trend. It’s built into how these medications are evaluated and described at the labeling level.

2) What “exercise guidelines” actually mean (numbers from real authorities)

Most reputable health guidance doesn’t say “do this exact workout plan.” Instead, it gives weekly targets that are realistic, measurable, and tied to broad health outcomes.

For adults, the most commonly cited targets come from U.S. and global public health guidance:

  • CDC (U.S.): Aim for 150 minutes a week of moderate-intensity activity (or 75 minutes vigorous), plus muscle-strengthening activity at least 2 days/week. CDC adult guidelines
  • Physical Activity Guidelines for Americans (HHS/health.gov): similar weekly targets, with examples and definitions of intensity. Official PDF
  • WHO (global): recommends 150–300 minutes of moderate-intensity activity weekly (or equivalent) plus muscle strengthening on 2+ days. WHO guideline page

If you’re on (or considering) a GLP-1 medication, these same general targets are often used as a reference point—because they’re public-health standards, not “one clinic’s opinion.”

3) Why strength training gets mentioned so often (especially during weight loss)

When people lose weight—no matter how—they can lose a mix of fat mass and fat-free mass (including muscle). One reason muscle-strengthening activity is emphasized in major guidelines is that maintaining muscle supports strength, function, and long-term health.

A recent systematic review in BMJ Open Sport & Exercise Medicine concluded that adding resistance exercise during weight loss can help attenuate loss of fat-free mass and improve body composition outcomes. BMJ Open SEM review

If you want a plain-English “why this matters” explanation from a U.S. aging/health authority, the National Institute on Aging also discusses how strength training supports function and independence over time: NIA overview

Bottom line: if someone is trying to lose weight (with or without medication), “just do cardio” is not the whole story. A balanced approach usually includes some form of muscle-strengthening activity—again, ideally discussed with a clinician if you have medical risks.

4) Safety basics when combining GLP-1 meds and exercise (non-medical, practical, and cautious)

This section stays intentionally conservative. Not because exercise is “bad,” but because GLP-1 medications can affect appetite and gastrointestinal tolerance, and people vary a lot.

  • Read the official medication guide / label (not just marketing pages). FDA labels list contraindications, warnings, and common adverse reactions. (Start points: Wegovy, Zepbound)
  • If you have any chronic condition, prior injuries, or symptoms that worry you, don’t “push through” based on a blog plan. Get individualized clearance.
  • Don’t treat weight loss speed as a score. Sustainable habits and safety matter more than racing a timeline.

If you’re looking for the “correct way,” the best answer is usually: use the FDA label + public health activity targets as guardrails, then personalize with a qualified clinician who can account for your medical history.

5) Telehealth GLP-1 programs: how to verify legitimacy (in minutes)

Telehealth can be convenient. But convenience is exactly why verification matters. Here are “checkable” steps that don’t require medical expertise.

A) Verify clinician credentials (don’t assume)

In the U.S., clinician licensure is handled at the state level. Many state medical boards have public license lookup tools, and national orgs aggregate license/discipline info.

  • Federation of State Medical Boards (FSMB): fsmb.org
  • DocInfo (license + board actions database connected to FSMB data): docinfo.org

B) Verify the pharmacy side (this is where people get fooled)

The FDA’s guidance for buying prescription meds online is straightforward: use state-licensed pharmacies and verify licensing rather than trusting a badge or logo.

C) Be extra cautious with “unapproved” or questionable supply chains

The FDA has repeatedly warned about counterfeit and illegally marketed GLP-1 products, including versions sold online that claim to be semaglutide or tirzepatide. If you’re seeing “too good to be true” pricing or unclear sourcing, that’s the moment to slow down and verify.

  • FDA: Concerns with unapproved GLP-1 drugs used for weight loss: FDA safety page
  • FDA warning on counterfeit Ozempic in the U.S. supply chain: FDA notice

Simple rule: if a site can’t clearly explain who the prescriber is, how prescriptions are handled, and what licensed pharmacy dispenses the medication, you’re missing basic verification information.

6) A small real-world example (LevelsRx), without turning this into an ad

Sometimes it helps to see how these checks look in the real world.

LevelsRx (levelsrx.com) describes itself as an online, clinician-guided weight management program and includes GLP-1 medications in its offering. On its site, LevelsRx also makes an “average results” style statement (for example, that patients lose a certain percentage of body weight on average). Source: LevelsRx homepage

How to treat statements like this: as company-reported marketing information—not as clinical proof, not as a guarantee, and not as something you should repeat as a medical claim. If you want to mention a provider’s reported outcomes in an informational article, the honest way is:

  • Label it clearly as “reported by the company” (not a study outcome).
  • Ask what “average” means (time period, sample size, inclusion/exclusion, drop-outs).
  • Compare it to the clinical trial outcomes summarized in FDA labeling (where methods are described and results are contextualized).

This is also the same standard you should apply to any telehealth provider—LevelsRx included. The goal is not “trust,” it’s verification.

7) If you want the “correct way” to combine GLP-1 meds and exercise, here’s the safest framework

This is the closest thing to a “correct approach” that stays evidence-aligned and avoids pretending your situation is identical to anyone else’s:

  1. Start with official sources: FDA label for the specific medication + national activity guidelines (CDC/HHS/WHO).
  2. Decide what you’re trying to improve: metabolic health, fitness, strength, mobility, adherence—then choose activity that matches (and that you can actually keep doing).
  3. Prioritize safety and consistency over intensity: the best routine is the one you can repeat without injuring yourself or quitting after two weeks.
  4. Use verification steps if telehealth is involved: clinician license + pharmacy legitimacy + clear cancellation/refund policies + responsive support.
  5. Loop a clinician in if you have any risk factors, symptoms, or questions about suitability.

If you want to go deeper, a good “next step” is to read the full prescribing information for any GLP-1 you’re considering (Wegovy / Zepbound, etc.), then bring your questions to a licensed professional. That’s slower than hype, but it’s how people avoid preventable mistakes.

Reminder: This article is not medical advice. Talk to a doctor or qualified clinician before starting a prescription GLP-1 medication, and before beginning or significantly changing an exercise routine.